Literature DB >> 21783579

In vitro toxicity of antimicrobials on RTG-2 and RTL-W1 fish cell lines.

Mar Babín1, Sara Boleas, José Vicente Tarazona.   

Abstract

This study proposed a battery of endpoints based on in vitro fish cell lines. Two fish cell lines and four toxicity endpoints are considered. The tetracycline (TC), oxytetracycline (OTC), sulfachlorpyridazine (SCP), and septrin(®) (ST) were selected as model antimicrobials and chlorpyrifos as positive control. EROD was induced by septrin(®) (formulation containing sulfamethoxazole and trimethoprim) at concentrations higher than 20mg/L, but inhibited by tetracycline, oxytetracycline and chlorpyrifos. Dose dependent inhibition responses were observed for β-galactosidase (β-Gal) activity in cells exposed to septrin(®), tetracycline or oxytetracycline. The EROD EC50s ranged between 2.29×10(-2)mg/L (chlorpyrifos) and 167.63mg/L (tetracycline). The β-Gal EC50s ranged between 22.1 (septrin(®)) and 84.59mg/L (tetracycline). Data suggest that in vitro testing using a battery of endpoints can be a cost-effective solution for screening the toxicity of antimicrobials on fish. The absence of in vitro effects at concentrations well above those expected/measured in the environment may replace the need for conducting acute lethality tests on fish.

Entities:  

Year:  2005        PMID: 21783579     DOI: 10.1016/j.etap.2004.11.005

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  2 in total

1.  Are fish and standardized FETAX assays protective enough for amphibians? A case study on Xenopus laevis larvae assay with biologically active substances present in livestock wastes.

Authors:  Federica Martini; José V Tarazona; M Victoria Pablos
Journal:  ScientificWorldJournal       Date:  2012-05-01

2.  Visible-Light-Driven Photocatalytic Degradation of Tetracycline Using Heterostructured Cu2O-TiO2 Nanotubes, Kinetics, and Toxicity Evaluation of Degraded Products on Cell Lines.

Authors:  Manisha Sharma; Mrinal Kanti Mandal; Shailesh Pandey; Ravi Kumar; Kashyap Kumar Dubey
Journal:  ACS Omega       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.